Disorder "Astrocytoma"
                    
                
                Found 40 records
            Disorder information
                Disorder name:
                            Astrocytoma 
                            Disoder ID:
                            
                            Synonyms:
                                Astrocytic tumor,astrocytoma of Cerebrum,astrocytoma of brain,astrocytoma, no ICD-O subtype,astroglioma,cerebral astrocytoma 
                            Definition:
                            Astrocytoma is a neoplasm of the central nervous system derived from astrocytes. Astrocytes are a type of glial cell, and thus astrocytoma is a subtype of glioma. 
                        Modifier statisitcs
                Record:
                            40 
                            Gene:
                            15 
                            Variant:
                            40 
                            Reference:
                            1 
                            Effect type:
                            
                                Expressivity(40)
                                    
                                 
                            
                            Modifier effect:
                            
                                Altered survival time(40)
                                    
                                 
                            
                        | Modifier gene | Variant | Effect type | Modifier effect | Evidence | Effect | PubMed ID | 
|---|---|---|---|---|---|---|
| PTPRN2 | PTPRN2:p.Glu121* | Expressivity | Altered survival time | Study on mouse strains | A subset of these genes shows male-specific correlations to glioblastoma patient survival time and represents strong candidates for the Arlm1 modifier gene.more | more | 
| NCAPG2 | NCAPG2:p.Glu588* | Expressivity | Altered survival time | Study on mouse strains | A subset of these genes shows male-specific correlations to glioblastoma patient survival time and represents strong candidates for the Arlm1 modifier gene.more | more | 
| NCAPG2:p.Phe1062* | Expressivity | Altered survival time | Study on mouse strains | A subset of these genes shows male-specific correlations to glioblastoma patient survival time and represents strong candidates for the Arlm1 modifier gene.more | more | |
| NCAPG2:p.Val1101* | Expressivity | Altered survival time | Study on mouse strains | A subset of these genes shows male-specific correlations to glioblastoma patient survival time and represents strong candidates for the Arlm1 modifier gene.more | more | |
| ITGB8 | ITGB8:p.Ala652* | Expressivity | Altered survival time | Study on mouse strains | A subset of these genes shows male-specific correlations to glioblastoma patient survival time and represents strong candidates for the Arlm1 modifier gene.more | more | 
| ESYT2 | ESYT2:p.Ala529* | Expressivity | Altered survival time | Study on mouse strains | A subset of these genes shows male-specific correlations to glioblastoma patient survival time and represents strong candidates for the Arlm1 modifier gene.more | more | 
| ESYT2:p.Val893* | Expressivity | Altered survival time | Study on mouse strains | A subset of these genes shows male-specific correlations to glioblastoma patient survival time and represents strong candidates for the Arlm1 modifier gene.more | more | |
| EML1 | EML1:p.Ser207* | Expressivity | Altered survival time | Study on mouse strains | A subset of these genes shows male-specific correlations to glioblastoma patient survival time and represents strong candidates for the Arlm1 modifier gene.more | more | 
| DICER1 | DICER1:p.Cys1604* | Expressivity | Altered survival time | Study on mouse strains | A subset of these genes shows male-specific correlations to glioblastoma patient survival time and represents strong candidates for the Arlm1 modifier gene.more | more | 
| CDCA7L | CDCA7L:p.Ser117* | Expressivity | Altered survival time | Study on mouse strains | A subset of these genes shows male-specific correlations to glioblastoma patient survival time and represents strong candidates for the Arlm1 modifier gene.more | more |